in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
CPhI: Actavis Expands into New Markets, Will Enter Biosimilars
3:18 AM MDT | October 21, 2009 | Deepti Ramesh in Madrid
Generic pharmaceuticals manufacturer Actavis (Hafnarfjordur, Iceland) says the company is in the process of expanding its presence in regions such as Japan, Mideast and South America, and it also closely monitors the biosimilar market and related activities within the business sector. Actavis says that biosimilars will play a major role in the generics industry in the future. Biosimilars are approved versions of innovator biopharmaceutical products introduced after patent expiry. A recent report by research and consulting firm Markets and Markets (Wilmington, DE)...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee